9
Apr
2025

SHIRATORI PHARMACEUTICAL CO.,LTD.

Exhibitor at CPHI Japan 2025 stand 6F-14
About Us

Shiratori Pharmaceutical is an API manufacturer in Japan focusing on APIs in niche markets such as rare diseases, rare oncology, neurology, etc. including high potency APIs. Manufacturing patents have been applied for Tafamidis and Eltrombopag in Japan.
Please find API pipeline below:
- Trametinib
- Cabazitaxel Acetonate
- Opicapone
- Ixazomib Citrate
- Brexpiprazole
- Valbenazine Tosilate
- Esaxerenone
- Pemafibrate
- Omidenepag
- Daprodustat- Macitentan
- Riociguat
- Selexipag
- Tafamidis

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • JP
  • 2020
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Primary activities
API Producer
View company profile
Contact info
  • +81-9046088039
  • Website
  • JBSL Kanda Building 7F, 12 Kanda Higashi Matsushita, 101-0042, Chiyoda-ku, Tokyo-to, Japan
Show contact info Hide contact info
Event information
CPHI Japan 2025
  • 09 Apr 2025 – 11 Apr 2025
  • East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
  • Visit us at stand 6F-14

Products Featured at CPHI Japan 2025